The upregulation of LINC00680 in ESCC tumor samples and its significant contribution to ESCC malignant phenotypes prompted us to exploit the potential of LINC00680 as a therapeutic target by using ASO. Here, LINC00680 is linked to esophageal squamous cell carcinoma.